Plain-English translation of NCT05976139 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a specialized laser treatment called micropulsed subthreshold laser to help reduce swelling and fluid buildup in the retina (the light-sensing layer at the back of your eye) in people with inherited retinal dystrophies. The treatment is being offered to patients whose swelling hasn't improved enough with other common treatments like diuretic pills or steroid injections. Researchers hope this laser approach may offer a new option for managing this complication.
Many people with inherited retinal diseases develop fluid buildup in a critical part of the eye called the macula, which worsens vision. Current treatments—like diuretic pills or injections—don't work well enough for some patients, and they can have side effects or stop working over time. This trial is exploring whether the micropulsed laser might help patients who haven't had good results with standard care.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive one or more sessions of micropulsed laser treatment targeted at the fluid buildup in your macula. Between treatments, you will have regular follow-up appointments where your eye doctor will use imaging scans to measure whether the swelling is improving. The study is small (about 10 participants) and involves patients whose other treatment options have been exhausted.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy